Click for best price
Transmucosal Drug Delivery Market Size, Share 2022
This report contains market size and forecasts of Transmucosal Drug Delivery in Global, including the following market information:
Global Transmucosal Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Transmucosal Drug Delivery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Passive Transdermal Drug Delivery Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Transmucosal Drug Delivery include 3M Pharmaceuticals, Acrux Limited, ALZA Corporation, Antares Pharma, Inc., Apricus BioSciences, Inc, Aveva Drug Delivery Systems, Corium International, Inc, DURECT Corporation and Generex Biotechnology Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Transmucosal Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transmucosal Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Transmucosal Drug Delivery Market Segment Percentages, by Type, 2021 (%)
Passive Transdermal Drug Delivery
Active Transdermal Drug Delivery
Global Transmucosal Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Transmucosal Drug Delivery Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Transmucosal Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Transmucosal Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transmucosal Drug Delivery revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Transmucosal Drug Delivery revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M Pharmaceuticals
Acrux Limited
ALZA Corporation
Antares Pharma, Inc.
Apricus BioSciences, Inc
Aveva Drug Delivery Systems
Corium International, Inc
DURECT Corporation
Generex Biotechnology Corporation
Inovio Pharmaceuticals, Inc.
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
MedPharm LTD
Mylan, Inc.
Nemaura Pharma Ltd
Nitto Denko Corporation
Noven Pharmaceuticals, Inc.
Pantec Biosolutions AG
Tapemark
tesa Labtec GmbH
TEVA Pharmaceutical Industries Ltd.
Zosano Pharma
| Report Attributes |
Report Details |
| Report Title |
Transmucosal Drug Delivery Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
117 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Transmucosal Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transmucosal Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transmucosal Drug Delivery Overall Market Size
2.1 Global Transmucosal Drug Delivery Market Size: 2021 VS 2028
2.2 Global Transmucosal Drug Delivery Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Transmucosal Drug Delivery Players in Global Market
3.2 Top Global Transmucosal Drug Delivery Companies Ranked by Revenue
3.3 Global Transmucosal Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Transmucosal Drug Delivery Companies in Global Market, by Revenue in 2021
3.5 Global Companies Transmucosal Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Transmucosal Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Transmucosal Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Transmucosal Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Transmucosal Drug Delivery Market Size Markets, 2021 & 2028
4.1.2 Passive Transdermal Drug Delivery
4.1.3 Active Transdermal Drug Delivery
4.2 By Type - Global Transmucosal Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Transmucosal Drug Delivery Revenue, 2017-2022
4.2.2 By Type - Global Transmucosal Drug Delivery Revenue, 2023-2028
4.2.3 By Type - Global Transmucosal Drug Delivery Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Transmucosal Drug Delivery Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Transmucosal Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Transmucosal Drug Delivery Revenue, 2017-2022
5.2.2 By Application - Global Transmucosal Drug Delivery Revenue, 2023-2028
5.2.3 By Application - Global Transmucosal Drug Delivery Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Transmucosal Drug Delivery Market Size, 2021 & 2028
6.2 By Region - Global Transmucosal Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Transmucosal Drug Delivery Revenue, 2017-2022
6.2.2 By Region - Global Transmucosal Drug Delivery Revenue, 2023-2028
6.2.3 By Region - Global Transmucosal Drug Delivery Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Transmucosal Drug Delivery Revenue, 2017-2028
6.3.2 US Transmucosal Drug Delivery Market Size, 2017-2028
6.3.3 Canada Transmucosal Drug Delivery Market Size, 2017-2028
6.3.4 Mexico Transmucosal Drug Delivery Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Transmucosal Drug Delivery Revenue, 2017-2028
6.4.2 Germany Transmucosal Drug Delivery Market Size, 2017-2028
6.4.3 France Transmucosal Drug Delivery Market Size, 2017-2028
6.4.4 U.K. Transmucosal Drug Delivery Market Size, 2017-2028
6.4.5 Italy Transmucosal Drug Delivery Market Size, 2017-2028
6.4.6 Russia Transmucosal Drug Delivery Market Size, 2017-2028
6.4.7 Nordic Countries Transmucosal Drug Delivery Market Size, 2017-2028
6.4.8 Benelux Transmucosal Drug Delivery Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Transmucosal Drug Delivery Revenue, 2017-2028
6.5.2 China Transmucosal Drug Delivery Market Size, 2017-2028
6.5.3 Japan Transmucosal Drug Delivery Market Size, 2017-2028
6.5.4 South Korea Transmucosal Drug Delivery Market Size, 2017-2028
6.5.5 Southeast Asia Transmucosal Drug Delivery Market Size, 2017-2028
6.5.6 India Transmucosal Drug Delivery Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Transmucosal Drug Delivery Revenue, 2017-2028
6.6.2 Brazil Transmucosal Drug Delivery Market Size, 2017-2028
6.6.3 Argentina Transmucosal Drug Delivery Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Transmucosal Drug Delivery Revenue, 2017-2028
6.7.2 Turkey Transmucosal Drug Delivery Market Size, 2017-2028
6.7.3 Israel Transmucosal Drug Delivery Market Size, 2017-2028
6.7.4 Saudi Arabia Transmucosal Drug Delivery Market Size, 2017-2028
6.7.5 UAE Transmucosal Drug Delivery Market Size, 2017-2028
7 Players Profiles
7.1 3M Pharmaceuticals
7.1.1 3M Pharmaceuticals Corporate Summary
7.1.2 3M Pharmaceuticals Business Overview
7.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Major Product Offerings
7.1.4 3M Pharmaceuticals Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.1.5 3M Pharmaceuticals Key News
7.2 Acrux Limited
7.2.1 Acrux Limited Corporate Summary
7.2.2 Acrux Limited Business Overview
7.2.3 Acrux Limited Transmucosal Drug Delivery Major Product Offerings
7.2.4 Acrux Limited Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.2.5 Acrux Limited Key News
7.3 ALZA Corporation
7.3.1 ALZA Corporation Corporate Summary
7.3.2 ALZA Corporation Business Overview
7.3.3 ALZA Corporation Transmucosal Drug Delivery Major Product Offerings
7.3.4 ALZA Corporation Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.3.5 ALZA Corporation Key News
7.4 Antares Pharma, Inc.
7.4.1 Antares Pharma, Inc. Corporate Summary
7.4.2 Antares Pharma, Inc. Business Overview
7.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Major Product Offerings
7.4.4 Antares Pharma, Inc. Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.4.5 Antares Pharma, Inc. Key News
7.5 Apricus BioSciences, Inc
7.5.1 Apricus BioSciences, Inc Corporate Summary
7.5.2 Apricus BioSciences, Inc Business Overview
7.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Major Product Offerings
7.5.4 Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.5.5 Apricus BioSciences, Inc Key News
7.6 Aveva Drug Delivery Systems
7.6.1 Aveva Drug Delivery Systems Corporate Summary
7.6.2 Aveva Drug Delivery Systems Business Overview
7.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Major Product Offerings
7.6.4 Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.6.5 Aveva Drug Delivery Systems Key News
7.7 Corium International, Inc
7.7.1 Corium International, Inc Corporate Summary
7.7.2 Corium International, Inc Business Overview
7.7.3 Corium International, Inc Transmucosal Drug Delivery Major Product Offerings
7.7.4 Corium International, Inc Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.7.5 Corium International, Inc Key News
7.8 DURECT Corporation
7.8.1 DURECT Corporation Corporate Summary
7.8.2 DURECT Corporation Business Overview
7.8.3 DURECT Corporation Transmucosal Drug Delivery Major Product Offerings
7.8.4 DURECT Corporation Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.8.5 DURECT Corporation Key News
7.9 Generex Biotechnology Corporation
7.9.1 Generex Biotechnology Corporation Corporate Summary
7.9.2 Generex Biotechnology Corporation Business Overview
7.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Major Product Offerings
7.9.4 Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.9.5 Generex Biotechnology Corporation Key News
7.10 Inovio Pharmaceuticals, Inc.
7.10.1 Inovio Pharmaceuticals, Inc. Corporate Summary
7.10.2 Inovio Pharmaceuticals, Inc. Business Overview
7.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Major Product Offerings
7.10.4 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.10.5 Inovio Pharmaceuticals, Inc. Key News
7.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
7.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Corporate Summary
7.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
7.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Major Product Offerings
7.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Key News
7.12 MedPharm LTD
7.12.1 MedPharm LTD Corporate Summary
7.12.2 MedPharm LTD Business Overview
7.12.3 MedPharm LTD Transmucosal Drug Delivery Major Product Offerings
7.12.4 MedPharm LTD Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.12.5 MedPharm LTD Key News
7.13 Mylan, Inc.
7.13.1 Mylan, Inc. Corporate Summary
7.13.2 Mylan, Inc. Business Overview
7.13.3 Mylan, Inc. Transmucosal Drug Delivery Major Product Offerings
7.13.4 Mylan, Inc. Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.13.5 Mylan, Inc. Key News
7.14 Nemaura Pharma Ltd
7.14.1 Nemaura Pharma Ltd Corporate Summary
7.14.2 Nemaura Pharma Ltd Business Overview
7.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Major Product Offerings
7.14.4 Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.14.5 Nemaura Pharma Ltd Key News
7.15 Nitto Denko Corporation
7.15.1 Nitto Denko Corporation Corporate Summary
7.15.2 Nitto Denko Corporation Business Overview
7.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Major Product Offerings
7.15.4 Nitto Denko Corporation Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.15.5 Nitto Denko Corporation Key News
7.16 Noven Pharmaceuticals, Inc.
7.16.1 Noven Pharmaceuticals, Inc. Corporate Summary
7.16.2 Noven Pharmaceuticals, Inc. Business Overview
7.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Major Product Offerings
7.16.4 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.16.5 Noven Pharmaceuticals, Inc. Key News
7.17 Pantec Biosolutions AG
7.17.1 Pantec Biosolutions AG Corporate Summary
7.17.2 Pantec Biosolutions AG Business Overview
7.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Major Product Offerings
7.17.4 Pantec Biosolutions AG Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.17.5 Pantec Biosolutions AG Key News
7.18 Tapemark
7.18.1 Tapemark Corporate Summary
7.18.2 Tapemark Business Overview
7.18.3 Tapemark Transmucosal Drug Delivery Major Product Offerings
7.18.4 Tapemark Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.18.5 Tapemark Key News
7.19 tesa Labtec GmbH
7.19.1 tesa Labtec GmbH Corporate Summary
7.19.2 tesa Labtec GmbH Business Overview
7.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Major Product Offerings
7.19.4 tesa Labtec GmbH Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.19.5 tesa Labtec GmbH Key News
7.20 TEVA Pharmaceutical Industries Ltd.
7.20.1 TEVA Pharmaceutical Industries Ltd. Corporate Summary
7.20.2 TEVA Pharmaceutical Industries Ltd. Business Overview
7.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Major Product Offerings
7.20.4 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.20.5 TEVA Pharmaceutical Industries Ltd. Key News
7.21 Zosano Pharma
7.21.1 Zosano Pharma Corporate Summary
7.21.2 Zosano Pharma Business Overview
7.21.3 Zosano Pharma Transmucosal Drug Delivery Major Product Offerings
7.21.4 Zosano Pharma Transmucosal Drug Delivery Revenue in Global Market (2017-2022)
7.21.5 Zosano Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Transmucosal Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Transmucosal Drug Delivery Market Drivers in Global Market
Table 3. Transmucosal Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Transmucosal Drug Delivery in Global Market
Table 5. Top Transmucosal Drug Delivery Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Transmucosal Drug Delivery Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Transmucosal Drug Delivery Revenue Share by Companies, 2017-2022
Table 8. Global Companies Transmucosal Drug Delivery Product Type
Table 9. List of Global Tier 1 Transmucosal Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transmucosal Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Transmucosal Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Transmucosal Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Transmucosal Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Transmucosal Drug Delivery Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Transmucosal Drug Delivery Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Transmucosal Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Transmucosal Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Transmucosal Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Transmucosal Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Transmucosal Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 30. 3M Pharmaceuticals Corporate Summary
Table 31. 3M Pharmaceuticals Transmucosal Drug Delivery Product Offerings
Table 32. 3M Pharmaceuticals Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 33. Acrux Limited Corporate Summary
Table 34. Acrux Limited Transmucosal Drug Delivery Product Offerings
Table 35. Acrux Limited Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 36. ALZA Corporation Corporate Summary
Table 37. ALZA Corporation Transmucosal Drug Delivery Product Offerings
Table 38. ALZA Corporation Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 39. Antares Pharma, Inc. Corporate Summary
Table 40. Antares Pharma, Inc. Transmucosal Drug Delivery Product Offerings
Table 41. Antares Pharma, Inc. Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 42. Apricus BioSciences, Inc Corporate Summary
Table 43. Apricus BioSciences, Inc Transmucosal Drug Delivery Product Offerings
Table 44. Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 45. Aveva Drug Delivery Systems Corporate Summary
Table 46. Aveva Drug Delivery Systems Transmucosal Drug Delivery Product Offerings
Table 47. Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 48. Corium International, Inc Corporate Summary
Table 49. Corium International, Inc Transmucosal Drug Delivery Product Offerings
Table 50. Corium International, Inc Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 51. DURECT Corporation Corporate Summary
Table 52. DURECT Corporation Transmucosal Drug Delivery Product Offerings
Table 53. DURECT Corporation Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 54. Generex Biotechnology Corporation Corporate Summary
Table 55. Generex Biotechnology Corporation Transmucosal Drug Delivery Product Offerings
Table 56. Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 57. Inovio Pharmaceuticals, Inc. Corporate Summary
Table 58. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product Offerings
Table 59. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 60. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Corporate Summary
Table 61. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product Offerings
Table 62. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 63. MedPharm LTD Corporate Summary
Table 64. MedPharm LTD Transmucosal Drug Delivery Product Offerings
Table 65. MedPharm LTD Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 66. Mylan, Inc. Corporate Summary
Table 67. Mylan, Inc. Transmucosal Drug Delivery Product Offerings
Table 68. Mylan, Inc. Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 69. Nemaura Pharma Ltd Corporate Summary
Table 70. Nemaura Pharma Ltd Transmucosal Drug Delivery Product Offerings
Table 71. Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 72. Nitto Denko Corporation Corporate Summary
Table 73. Nitto Denko Corporation Transmucosal Drug Delivery Product Offerings
Table 74. Nitto Denko Corporation Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 75. Noven Pharmaceuticals, Inc. Corporate Summary
Table 76. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product Offerings
Table 77. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 78. Pantec Biosolutions AG Corporate Summary
Table 79. Pantec Biosolutions AG Transmucosal Drug Delivery Product Offerings
Table 80. Pantec Biosolutions AG Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 81. Tapemark Corporate Summary
Table 82. Tapemark Transmucosal Drug Delivery Product Offerings
Table 83. Tapemark Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 84. tesa Labtec GmbH Corporate Summary
Table 85. tesa Labtec GmbH Transmucosal Drug Delivery Product Offerings
Table 86. tesa Labtec GmbH Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 87. TEVA Pharmaceutical Industries Ltd. Corporate Summary
Table 88. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product Offerings
Table 89. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 90. Zosano Pharma Corporate Summary
Table 91. Zosano Pharma Transmucosal Drug Delivery Product Offerings
Table 92. Zosano Pharma Transmucosal Drug Delivery Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Transmucosal Drug Delivery Segment by Type in 2021
Figure 2. Transmucosal Drug Delivery Segment by Application in 2021
Figure 3. Global Transmucosal Drug Delivery Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Transmucosal Drug Delivery Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Transmucosal Drug Delivery Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Transmucosal Drug Delivery Revenue in 2021
Figure 8. By Type - Global Transmucosal Drug Delivery Revenue Market Share, 2017-2028
Figure 9. By Application - Global Transmucosal Drug Delivery Revenue Market Share, 2017-2028
Figure 10. By Region - Global Transmucosal Drug Delivery Revenue Market Share, 2017-2028
Figure 11. By Country - North America Transmucosal Drug Delivery Revenue Market Share, 2017-2028
Figure 12. US Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Transmucosal Drug Delivery Revenue Market Share, 2017-2028
Figure 16. Germany Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 17. France Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Transmucosal Drug Delivery Revenue Market Share, 2017-2028
Figure 24. China Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 28. India Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Transmucosal Drug Delivery Revenue Market Share, 2017-2028
Figure 30. Brazil Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Transmucosal Drug Delivery Revenue Market Share, 2017-2028
Figure 33. Turkey Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Transmucosal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 37. 3M Pharmaceuticals Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Acrux Limited Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. ALZA Corporation Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Antares Pharma, Inc. Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Corium International, Inc Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. DURECT Corporation Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. MedPharm LTD Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Mylan, Inc. Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Nitto Denko Corporation Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Pantec Biosolutions AG Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Tapemark Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. tesa Labtec GmbH Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Zosano Pharma Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
